Company news
Rebus Hldgs Inc. news in 2017
Rebus Hldgs Inc.'s news releases, calls and decks from 2017, newest first.
Inspyr Therapeutics Announces Research Collaboration with the National Institutes of Health
October 23, 2017
Inspyr Therapeutics Announces Research Collaboration with NYU Winthrop Hospital
October 4, 2017
Inspyr Therapeutics Announces Research Collaboration with University of Virginia School of Medicine
October 2, 2017
Inspyr Therapeutics and Lewis and Clark Pharmaceuticals Complete Merger
September 13, 2017
Inspyr Therapeutics Announces Private Placement of Senior Convertible Debentures
September 12, 2017
Inspyr Therapeutics and Lewis and Clark Pharmaceuticals to Merge
May 30, 2017
Inspyr Therapeutics Signs Commitment Letter with Milost Global
March 28, 2017
Inspyr Therapeutics Secures a $100 Million Financing Agreement from Milost Global
March 17, 2017
Inspyr Therapeutics Appoints NIH Veterans to Lead New Translational Medicine Initiatives and Pipeline Expansion
March 6, 2017
Inspyr Therapeutics Initiates Mipsagargin Combination Therapy Program for Gastric Cancer
February 22, 2017
Inspyr Therapeutics Initiates Mipsagargin with Nexavar® Combination Therapy Programs for Liver Cancer
January 3, 2017